Julie K. Casteel, Chief Sales/Marketing Officer of IBEX Ltd (IBEX), had 3,228 performance-based stock units vest and convert to common shares on 09/30/2025, increasing her holdings to 29,123 shares.
On 10/02/2025 she sold 806 shares at a weighted average price of $39.583 to satisfy tax-withholding obligations, leaving her with 28,317 beneficially owned shares. The filing states the PSU vesting followed certification of performance goals for the period ending 06/30/2025.
IBEX Ltd's Chief Operating Officer, David Martin Afdahl, had 3,228 performance-based stock units (PSUs) vest and convert into common shares on 09/30/2025 after certification of performance goals for the period ending 06/30/2025. To satisfy tax-withholding obligations related to that vesting, the reporting person sold 1,103 shares on 10/02/2025 at a weighted average price of $39.5818 per share. As a result of these transactions, the reporting person’s beneficial ownership declined from 58,214 shares following the PSU conversion to 57,111 shares after the sale. The Form 4 states the sales were required to cover taxes and were not discretionary trades.
IBEX Ltd insider report: Chief Financial Officer Taylor C. Greenwald had 4,196 performance-based stock units (PSUs) vest and convert into common shares on 09/30/2025, bringing total beneficial ownership to 37,757 shares.
On 10/02/2025 the reporting person sold 1,275 shares at a weighted average price of $39.5819 to satisfy tax withholding obligations related to the PSU vesting, leaving 36,482 shares beneficially owned. The Form 4 states the sales were not discretionary trades but were required to cover taxes; the filer offers to provide trade-level price details on request.
Robert Thomas Dechant, Chief Executive Officer and a director of IBEX Ltd (IBEX), had 14,524 performance-based stock units (PSUs) convert to common shares on September 30, 2025 after certification of performance goals for the period ending June 30, 2025. To satisfy tax-withholding obligations related to that vesting, 6,711 shares were sold in multiple trades on October 2, 2025 at a weighted average price of $39.5817 per share. Following these transactions, the reporting person beneficially owns 199,812 common shares.
Form 144 notice for IBEX Ltd (IBEX) reports a proposed sale of 2,295 common shares with an aggregate market value of $93,475.69. The sale is listed on NASDAQ and the approximate sale date is 09/19/2025. The securities were acquired on 09/18/2025 by vesting of a grant from the issuer, with 7,500 shares shown as acquired on that date. A prior sale by the same person, Taylor C Greenwald, recorded 438 shares sold on 08/26/2025 for $12,757.51. Broker listed: Global Shares Financial Services Inc.
IBEX Ltd (IBEX) reporting person Taylor C. Greenwald, Chief Financial Officer, sold 2,295 common shares on 09/19/2025 at $40.7302 per share. The Form 4 shows the sale was required to cover tax withholding for restricted stock units that vested and is not described as a discretionary trade. After the transaction the reporting person beneficially owned 33,561 shares, held directly. The filing was signed by an attorney-in-fact on 09/23/2025. No options, derivative transactions, or other compensatory arrangements are disclosed on this Form 4.
Julie K. Casteel, Chief Sales/Marketing Officer of IBEX Ltd (IBEX), reported a sale of common shares. On 09/16/2025 she disposed of 5,000 common shares at a price of $39.0002 per share, leaving her with 25,895 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 09/17/2025.
IBEX Ltd filed a Form 144 notice disclosing a proposed sale of 5,000 shares of its common stock by an insider. The filing names Charles Schwab as the broker and lists an approximate sale date of 09/16/2025 on Nasdaq. The shares were acquired as stock grants on 12/31/2018 and paid via equity compensation. The filing also reports a recent sale of 295 shares on 07/01/2025 for $8,592. The filer affirms no undisclosed material adverse information.
IBEX Ltd Form 4 summary: The filing by Bruce Neil Dawson reports transactions in IBEX Ltd (IBEX) on 09/16/2025. The reporting person executed an acquisition of 8,114 common shares (code M) at a reported price of $19.00, and two sales of common shares the same date: 8,114 shares sold at a weighted average price of $38.14 and 765 shares sold at a reported price of $38.2903. Following the reported transactions, the filing shows beneficial ownership levels of 13,371, 5,257, and 4,492 shares on the respective lines. The seller notes the sales were executed in multiple trades at prices ranging from $38.2901 to $38.35 and offers to provide further breakdowns on request. The form is signed by an attorney-in-fact, Lisa Lenstrohm, dated 09/17/2025.
IBEX Ltd insider Robert Thomas Dechant reported same-day non-derivative transactions on 09/16/2025. He acquired 45,027 common shares at $19.00, bringing his beneficial ownership to 237,026 shares (direct), and sold 45,027 common shares at $38.89, leaving 191,999 shares (direct) after the transactions. The Form 4 was signed by an attorney-in-fact on 09/17/2025.